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With more than 9.3 million cases and 480 000 
deaths recorded to date,1 COVID-19 pandemic 
has put global emergency preparedness and 
the capacity of national health systems to 
predict and respond to major emergencies 
under a sharp scrutiny. The response to the 
pandemic is focused on testing, case manage-
ment and control measures such as personal 
hygiene, quarantine and social distancing. 
However, in most African countries, as else-
where, these measures are not backed by reli-
able context- specific data. Instead, they are 
largely dependent on epidemic curves from 
China and Europe which appear to differ 
from those in sub- Saharan Africa. Given the 
massive economic and social disruptions 
occasioned by the control measures, govern-
ments and other stakeholders are desperate 
for accurate real- time data on the pandem-
ic’s progress and to inform intervention 
strategies. Furthermore, scarcity of medical 
and laboratory resources due to increased 
demand globally coupled with international 
travel restrictions has forced countries to look 
inwards for local innovations and adaptations 
in COVID-19 testing options and interven-
tions, as well as personal protective equip-
ment (PPE).
Consequently, attention has turned to 
the contribution of local researchers in the 
pandemic response and by extension, coun-
tries’ science preparedness. With respect to 
health emergencies, science preparedness can 
be defined as ‘a collaborative effort to establish 
and sustain a scientific research framework 
that can inform and enable emergency plan-
ners, responders and the whole community 
to better prepare for, respond to, and recover 
from major public health emergencies and 
disasters’.2 As such, science preparedness is 
an integral part of emergency responsiveness 
despite receiving less attention than health 
service preparedness. Although researchers, 
research support personnel, research infra-
structure and mobilisable resources form 
the core of science preparedness, mounting 
a robust science- backed emergency recovery 
response entails complex interplay between 
multiple elements and actors. As illustrated 
in figure 1, mechanisms to expedite ethical 
approval of emergency research should be in 
place to fast track the generation and sharing 
of the data and evidence required to inform 
response planning and implementation. On 
the other hand, research should be coor-
dinated to promote synergies and resource 
optimisation. Furthermore, rapid dissemina-
tion and translation of emergency research 
outputs calls for efficient channels of engage-
ment between researchers, state and non- 
state agencies, and the public.
Together, these elements define a respon-
sive and resilient research system that oper-
ates and provides reliable data even under 
crisis. Such a system cannot be hurriedly 
cobbled together at the dawn of an emer-
gency. Science preparedness should be 
embedded within a wider scientific capacity 
building agenda. Given the low research 
capacity in many Sub- Saharan African coun-
tries, there has been some anxiety and fear 
regarding the ability of the continent’s 
research community to provide scientific 
backup to COVID-19 response. However, 
the last decade or so has seen a significant 
increase in funding for research capacity in 
Africa. The inevitable question is whether this 
investment has impacted on the continent’s 
science preparedness. We address this ques-
tion by reflecting on how research expertise, 
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infrastructure and resources established under one of 
the largest networks for research capacity building in 
Africa has been mobilised for pandemic response and 
what factors have influenced the level and nature of the 
network’s involvement.
The African Research Coalition for Health (ARCH) is 
an umbrella network of 11 African- led consortia covering 
54 African research institutions and universities across 17 
Sub- Saharan countries whose aim is to build high- quality 
research capacity in the continent. Some consortia have 
a narrow focus Sub- SaharanAfrican Network for TB/HIV 
Research Excellence (SANTHE) focuses on HIV and 
tuberculosis, DevelopingExcellence in Leadership and 
Genetic Training for Malaria Elimination inSub- Saharan 
Africa (DELGEME) —malaria, MalariaResearch Capacity 
Development in West and Central Africa (MARCAD)—
malaria and - African Mental Health Research Initiative 
(AMARI)—mental health. Others such as the Initia-
tiveto Develop African Research Leaders (IDeAL), 
Makerere University – Uganda Virus Research Institute 
(UVRI) Centre of Excellence for Infection & Immunity 
Research and Training (MUII- plus), WestAfrican Centre 
for Cell Biology of Infectious Pathogens (WACCBIP) and 
TrainingHealth Researchers into Vocational Excellence 
(THRiVE) have a multidisease focus. AfricanScience 
Partnership for Intervention Research Excellence 
(Afrique- one ASPIRE) focuses on One Health imple-
mentation research while Sub- SaharanAfrican Consor-
tium for Advanced Biostatistical Training (SSACAB)’s 
key interest is in enhancing biostatistical leadership and 
capacity. Consortiumfor Advanced Research Training 
in Africa (CARTA+) combines an agenda to strengthen 
PhD training with multidisciplinary research capacity 
strengthening at local universities. A large portion of the 
funds for setting up the consortia came from the Well-
come Trust African Institutions Initiative grant in 2009 
and subsequently in 2015 from the Wellcome Trust, The 
Department for International Development (UKAID) 
and New Partnership for Africa’s Development Planning 
and Coordinating Agency through the African Academy 
of Sciences - Developing Excellence in Leadership, 
Training and Science Africa scheme (DELTAS).3 In addi-
tion, the consortia have also raised significant amounts 
of further funding from other sources across the globe. 
By the end of 2021, ARCH will have supported over 1000 
high- quality PhD and postdoctoral training covering most 
of the spheres of health research and similar numbers 
of Master’s training, and graduate research internships 
with the ultimate aim of creating a critical mass of African 
research leaders.
A quick survey across the members of ARCH 4 months 
into the pandemic revealed extensive mobilisation of 
Figure 1 Science preparedness as a component of health emergency preparedness.
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their expertise and resources towards the COVID-19 
response (table 1). The most urgent demand globally 
is for testing expertise and platforms. Because of their 
established biosciences capacity, many ARCH partner 
institutions were among the first COVID-19 testing and 
diagnostics training nodes in their respective countries. 
Beyond testing, the institutions have also deployed 
their surveillance systems, and expertise in epidemi-
ology, modelling and pathogen sequencing, a significant 
proportion of which was developed under the ARCH 
framework, to gather the population- level data needed 
to improve incidence estimates and transmission models 
reliability.4 In parallel, many ARCH- trained researchers 
are currently launching immunology and pathogenesis 
studies to inform COVID-19 drug and vaccine develop-
ment. Although clinical trials capacity in Sub- Saharan 
Africa is limited, ARCH has supported the development 
of some of the best capacity for trials in the region and 
at least four consortia are preparing to support clinical 
trials for COVID-19 vaccines and drugs.
The response to COVID-19 calls for a multisectoral, 
multiagency One- Health approach structured around 
core governmental teams supported by technical advi-
sors. Building on the links that ARCH consortia have 
established with their local state health agencies and in 
recognition of the expertise the consortia harbour, over 
30 ARCH- affiliated scientists and training fellows have 
been formally appointed to their respective national 
Table 1 Examples of capacities mobilised by members of African Research Coalition for Health (ARCH) for COVID-19 
response
Research capacity mobilised Activities Consortia involved
Molecular biology expertise and 
laboratory infrastructure
Supporting COVID-19 testing; validation of testing kits; 
sequencing SARS- CoV-2 to understand transmission pathway 
and to detect changes in the virus over time
IDeAL, MUII- plus, THRiVE, MARCAD, 
Afrique One- ASPIRE, DELGEME, 
CARTA+, WACCBIP
Epidemiology, statistical and 
mathematical modelling
COVID-19 data analysis and predictive modelling; statistical 
advisory roles for data analysis for national response teams 
and intervention trials
SSACAB, IDeAL, CARTA+
Surveillance platforms such as 
Health Demographic Surveillance 
Systems
Respiratory disease surveillance to estimate missed COVID-19 
cases; sero- surveillance to provide national prevalence 
estimates and estimation of COVID-19- related deaths outside 
the hospital setting
IDeAL, MARCAD, THRiVE, SSACAB, 
CARTA+
Immunology, clinical research, 
genetic susceptibility studies
Studies to understand genetic susceptibility, immunity and 
clinical manifestations of COVID-19 in the Africa population
SANTHE, IDeAL, MUII- plus, THRiVE
Clinical trials Trials for COVID-19 drugs for example, hydroxychloroquine, 
repurposed influenza drugs, vaccines and locally developed 
medical equipment such as ventilators; data analysis for 
clinical trials
IDeAL, THRiVE, MUIIPlus, MARCAD, 
SSACAB, CARTA+
Health systems and health 
economics
Assessing COVID-19 economic impact and health systems 
disruptions, including health workers experiences, health 
systems response and access to reproductive health systems.
Afrique One- ASPIRE, IDeAL, CARTA+
Social sciences and ethics research COVID-19 Knowledge Attitude and Practice Studies; studies 
on impact of lockdown on social well- being; studying and 
advising on expedited ethics approval process for COVID-19 
studies
Afrique One- ASPIRE, CARTA, IDeAL, 
MARCAD, THRIVE, SSACAB
Mental health research capacity Assessing the impact of lockdown on mental health and 
developing interventions including online support platforms
AMARI’ IDeAL
One Health platforms COVID-19 knowledge transformation for communication 
design by intersectoral stakeholders and community leaders
Afrique One- ASPIRE,
Policy analysis and links national 
response teams, and with other 
agencies
Technical advisors on national response teams; training 
health workers in COVID-19 testing and use of PPEs; training 
response team on data analysis
All consortia
Paedagogy expertise and 
information technology 
infrastructure
ARCH fellows trained in paedagogy supporting online teaching 
in universities to ensure learning continuity
CARTA+
Community and public engagement 
expertise and Information 
technology infrastructure
Hosting of and participation in COVID-19 webinars, television 
and radio shows and other media platform by ARCH fellows 
and scientists
All consortia
Fund raising for research and link 
with funders
Development of grant application to expand response activities 
beyond local funding; working with AAS to define local 
COVID-19 research priorities
All consortia
Research management Expedited research protocols ethic review; expedited grants 
application processing
All consortia
AAS, African Academy of Sciences; SARS- CoV-2, severe acute respiratory syndrome coronavirus 2.
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COVID-19 response teams to advise on a range of activ-
ities. Those with statistical background are providing 
support for data analysis and modelling. Social scientists, 
health systems, policy and mental health researchers 
are helping assess the impact of COVID-19 control poli-
cies on the economy, other health services, social and 
mental well- being5 and advising on mitigation strategies 
including control models using One- Health platforms. 
Further, several ARCH ethics researchers have been 
involved in developing guidelines for expedited ethics 
review and approval for COVID-19 studies.
We believe that the extensive involvement of ARCH 
researchers and training fellows in COVID-19 response 
reflects the quality of capacity built through ARCH. 
The unique feature of ARCH’s model is the underpin-
ning theory of change which encompasses four domains 
of scientific leadership: research training; scientific 
excellence; scientific citizenship and research manage-
ment. ARCH trainees acquire a high level of technical 
competence through a triad of high- quality supervi-
sion, mentorship and well- designed research projects. 
This competence is supplemented with leadership 
skills through scientific citizenship training including 
teaching, community and public engagement. ARCH 
also lays a strong emphasis on retention and nurturing 
of researchers beyond training. Without a conducive 
environment, many risks a stunted research career and 
may migrate out of Africa or research. ARCH, therefore, 
promotes an enabling environment within their partner 
institutions through the development of research infra-
structure and research management systems.
This broad view of research capacity building has 
generated a cohort of prolific African researchers 
many of whom are not only leading their own research 
programmes but are also fostering strong collaborations 
between the consortia and local ministries of health and 
other key health stakeholders to drive translation and 
implementation of research output. Furthermore, this 
approach inherently integrates preparedness for novel 
health challenges. Thus, when the pandemic reached 
Africa, the consortia were able to rapidly deploy and redi-
rect their expertise, research resources, infrastructures 
and links with health agencies to support response activi-
ties. Crucial to the response was the ability of the member 
institutions to rapidly adapt their research regulatory 
systems to expedite ethics review processes for COVID-19 
studies and applications for grants to support the studies.
The research capacity established by ARCH is a strong 
demonstration of the value of long- term and substan-
tial investment in research capacity building. However, 
the number of African researchers still falls far short of 
critical mass and many countries are still excluded from 
efforts such as ARCH due to insufficiency of funding. 
In the light of the current pandemic, we the directors 
of ARCH, urge African governments, and other research 
funders to seriously reflect on the commitments they 
have repeatedly made to build science capacity. Second, 
despite the expertise, infrastructure and resources that 
ARCH and other African institutions have mobilised for 
COVID-19 responses, the pandemic has revealed critical 
gaps in Africa’s science preparedness. Many institutions 
are hamstrung by an inability to procure key reagents, 
goods and services for laboratory and field- based research 
for COVID-19 and other diseases due to lockdown and 
travel restrictions. Although system- wide and impacting 
all sectors, these issues highlight the urgent need to 
strengthen institutional and national business conti-
nuity plans for research during major crises. We would, 
therefore, like to end this editorial with a call for more 
investments towards enhancing the resilience of national 
and global research procurement and supply systems in 
parallel with building capacity for research that is locally 
appropriate and responsive to context- specific priorities 
and needs.6
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